Danzen, the active ingredient of which is serrapeptase, is marketed as a prescription drug for the treatment of inflammation by Takeda Chemical Industries (takeda.co.jp).
The second most-recognized product in Europe is Voltaren,
with 15.5% of physicians known the brand. Voltaren is a prescription
nonsteroidal anti-inflammatory and antirheumatic agent marketed by Novartis
(novartis.com). Motrin and Advil are not among the most-recognized brands
in Europe. Danzen and Voltaren are not among the most-recognized brands
in the United States.
Marketing Research Companies
The cox-2 inhibitor Vioxx was the fourth most-recognized product in the United States, acknowledged by 11% of physicians. In Europe, 7.8% of physicians recognized Vioxx, making it the fifth most-recognized product. Vioxx is marketed by Merck & Co. (merck.com).
Naprosyn is the eighth most-recognized analgesic product in the United States and Europe. In the United States, 4.2% of physicians recognized the product, and in Europe, 3.4% of physicians recognized the product. Naprosyn is marketed by Roche (roche.com).
Brand
Institute (brandinstitute.com) surveyed more than 2,000 medical professionals
in North America and Europe to determine the most-recognizable brands
in the pain and inflammation category. The sample consists of physicians
and hospital and retail pharmacists. Brandpoll is a marketing tool designed
by Brand Institute to help clients monitor the competitive marketplace
and identify potential strengths and weakness of their brands.
Marketing Research Companies
